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conclusive.We conducteda prospectivestudyto systematicallyevaluate
the possibleroleof Epstein-Barr(EB)virusin KD.BetweenJune1991and
June1994,a totalof 55patientswithtypicalKDwereenrolledintothestudy.
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Immediate 1 year 2 years 4 yeara
:Ad (O/.) 1.7 i 1.7 1.9 + 1.6 3.5 l3.0* 8.6 *4.7*
:LP20 8.3 + 7.2 13.3 + 14.6 18.3 + 13.6* 19,5* 15.9*
Concordancerate (“A) 96 94 62* 78*
*P <0,05 vs. immediate
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